drug

HWK-007

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Whitehawk Therapeutics, Inc.

Timeline

Whitehawk reports Q2 2026 results, HWK-206 trial on track for Q3 start

Aug 6Quarterly updateWhitehawk Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.